(株)カイオム・バイオサイエンスの貸借残高情報

主市場	業種	証券コード/EDINET	英名称
東証GRT	医薬品	4583/E26096	Chiome Bioscience Inc.

公表日	公表	貸付残高	前週比	新規貸付成約高	前週比	借入残高	前週比	新規借入成約高	前週比
2026/06/05	日証協	13,597,654株	+1.96%	4,500,645株	-22.68%	15,522,636株	+0.93%	466,651株	-40.66%
2026/05/29	日証協	13,336,009株	-0.17%	5,820,542株	+96.45%	15,380,031株	+1.03%	786,344株	+68.17%
2026/05/22	日証協	13,358,057株	-0.43%	2,962,870株	-31.18%	15,223,831株	-0.61%	467,600株	-21.41%
2026/05/15	日証協	13,415,857株	+2.09%	4,305,200株	+14.66%	15,316,879株	+1.89%	595,004株	+174.37%
2026/05/08	日証協	13,141,709株	+2.39%	3,754,600株	+35.60%	15,033,321株	+1.11%	216,858株	-58.74%
2026/05/01	日証協	12,834,757株	+2.54%	2,768,900株	-11.98%	14,867,921株	+2.07%	525,602株	-40.58%
2026/04/24	日証協	12,517,009株	+0.23%	3,145,700株	+1.31%	14,566,758株	-0.37%	884,606株	+227.02%
2026/04/17	日証協	12,488,709株	+2.42%	3,105,100株	+24.64%	14,621,249株	-0.09%	270,506株	+24.34%
2026/04/10	日証協	12,193,386株	+0.16%	2,491,332株	+35.46%	14,633,842株	-0.08%	217,560株	-14.85%
2026/04/03	日証協	12,174,386株	-1.14%	1,839,228株	-54.38%	14,645,059株	-0.47%	255,513株	-59.28%
2026/03/27	日証協	12,315,258株	+2.69%	4,031,316株	+134.65%	14,713,550株	+1.70%	627,502株	-3.93%
2026/03/19	日証協	11,992,274株	+3.75%	1,717,984株	-42.97%	14,466,934株	+2.90%	653,185株	+45.18%
2026/03/13	日証協	11,558,726株	-13.60%	3,012,582株	-42.66%	14,059,349株	-6.16%	449,918株	-69.21%
2026/03/06	日証協	13,378,658株	+20.88%	5,253,584株	+64.39%	14,982,067株	+9.44%	1,461,148株	+132.43%
2026/02/27	日証協	11,068,042株	+0.29%	3,195,784株	+18.36%	13,689,567株	+0.68%	628,649株	+2.30%
2026/02/20	日証協	11,035,758株	+4.28%	2,700,000株	-18.38%	13,596,666株	+2.01%	614,501株	-6.28%
2026/02/13	日証協	10,582,610株	-4.98%	3,307,896株	+172.95%	13,328,665株	-2.81%	655,698株	+74.71%
2026/02/06	日証協	11,137,710株	-0.20%	1,211,900株	-50.19%	13,713,763株	+0.29%	375,308株	-22.55%
2026/01/30	日証協	11,160,310株	+4.75%	2,433,000株	+1.06%	13,674,061株	+2.20%	484,551株	-20.74%

※株式分割は考慮していませんのでご注意ください。